Suppr超能文献

使用非参数最优基准评估 I 期方法的网络应用程序。

A web application for evaluating Phase I methods using a non-parametric optimal benchmark.

机构信息

Division of Translational Research & Applied Statistics, Department of Public Health Sciences, The University of Virginia, Charlottesville, VA, USA.

出版信息

Clin Trials. 2017 Oct;14(5):553-557. doi: 10.1177/1740774517715456. Epub 2017 Jun 24.

Abstract

BACKGROUND/AIMS: In evaluating the performance of Phase I dose-finding designs, simulation studies are typically conducted to assess how often a method correctly selects the true maximum tolerated dose under a set of assumed dose-toxicity curves. A necessary component of the evaluation process is to have some concept for how well a design can possibly perform. The notion of an upper bound on the accuracy of maximum tolerated dose selection is often omitted from the simulation study, and the aim of this work is to provide researchers with accessible software to quickly evaluate the operating characteristics of Phase I methods using a benchmark.

METHODS

The non-parametric optimal benchmark is a useful theoretical tool for simulations that can serve as an upper limit for the accuracy of maximum tolerated dose identification based on a binary toxicity endpoint. It offers researchers a sense of the plausibility of a Phase I method's operating characteristics in simulation. We have developed an R shiny web application for simulating the benchmark.

RESULTS

The web application has the ability to quickly provide simulation results for the benchmark and requires no programming knowledge. The application is free to access and use on any device with an Internet browser.

CONCLUSION

The application provides the percentage of correct selection of the maximum tolerated dose and an accuracy index, operating characteristics typically used in evaluating the accuracy of dose-finding designs. We hope this software will facilitate the use of the non-parametric optimal benchmark as an evaluation tool in dose-finding simulation.

摘要

背景/目的:在评估 I 期剂量探索设计的性能时,通常进行模拟研究,以评估在一组假设的剂量-毒性曲线下,一种方法正确选择真实最大耐受剂量的频率。评估过程的一个必要组成部分是要有一些关于设计性能的概念。在模拟研究中,通常忽略了最大耐受剂量选择准确性的上限概念,本工作的目的是为研究人员提供一种易于使用的软件,以便使用基准快速评估 I 期方法的操作特征。

方法

非参数最优基准是一种有用的模拟理论工具,可作为基于二元毒性终点的最大耐受剂量识别准确性的上限。它为研究人员提供了一种对模拟中 I 期方法操作特征的合理性的认识。我们开发了一个 R shiny 网络应用程序来模拟基准。

结果

该网络应用程序能够快速提供基准的模拟结果,并且不需要编程知识。该应用程序可在任何具有 Internet 浏览器的设备上免费访问和使用。

结论

该应用程序提供了正确选择最大耐受剂量的百分比和准确性指数,这是评估剂量探索设计准确性的常用指标。我们希望这个软件将促进将非参数最优基准作为剂量探索模拟中的评估工具的使用。

相似文献

8
Simple benchmark for complex dose finding studies.复杂剂量探索研究的简易基准。
Biometrics. 2014 Jun;70(2):389-97. doi: 10.1111/biom.12158. Epub 2014 Feb 25.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验